CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases

JAVIER CABALLERO VILLARRASO2026-01-292026-01-29202310.3390/antib120200302-s2.0-85163733204https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/36571Drug DiscoveryImmunologyImmunology and AllergyCCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseasesreview article